Clinical Trials, page-289

First 289 Last

Share
Profile

Follow
Buckland

8,661 Posts.

1671

04/07/20

13:05

Post #: 45642684
Share

Originally posted by adreamer: ↑

haha you are a classic!
There are folks the see the glass half full but no one ever asks what it is full of. Then others that suggest the glass could be less than half and as time goes on the evaporation is happening increasingly, then others that don’t care that there is half a glass as if it ain’t full - what’s the point. Conspiracy theorists would question if the glass ever existed and that the government, company and ASX are lying to fool us all into false hope. Me, I think the glass is actually far more full than they are telling us and the scientific community are being particularly cautious for all the right reasons.

now to your question: below is all just my opinion- but I try to be logical and analytical.

Government funds: $3M allocated to WEHI for covid work. PharmAust has been, in part, drawing down on this. Other funding sources are from PharmAust (token costs have been in previous announcements) and see WEHI website for all of their funding sources. Should they need more coin, Greg Hunt would be listening as would PharmAust. I don’t think they have hit the wall yet.

Why no progress announcement on COVID:
WEHI are the subject matter experts on infectivity and infectious diseases. They are leading the research. They don’t need to work to the drum beat of PharmAust to be very frank about it. They are using their own and Australian government funding so they will determine their priorities and just a few days ago Dr Pellegrini was in the news with a c-find. (Quite impressive). He is also running the Hydroxychloroquine trial.
MPL is not their only horse in the stable - albeit looks like MPL is the pharma equivalent of WINX, with penicillin being the equivalent of Pharlap.
Doing a comparison analysis of MPL and MPLs is not like doing a school assignment. It is detailed and technical. There is a fairly high chance they are doing the actual yeasts in vitro with the comparison candidates. That takes time, then even more time to compile results and to get the report to a standard that will withstand peer reviews. We should not be mistaken, should MPL / MPLs be as effective against viruses like COVID-19, every country and every virologist in the world will instantly be as mesmerised as us; and some big Pharma be trying to discredit the findings to stop competition.
they need to develop info for clinicians and that is also extremely detailed as it is both a PH1 trial and all associated info about how to treat people of all ages and all conditions.

So there is a massive amount so work in all of the above and it all relies on a small number of highly skilled subject matter experts.

This vital detailed scientific work must be led by WEHI as they are the most appropriate experts.
PharmaAust may have struck gold but you don’t ask the fellas that found the gold to do a filling in your tooth.

So Bucky, no issues with you asking such questions and hope the above provides some thought provoking considerations to help guide your (and other’s) thinking.

Chill dude, the future is not so far away and negativity and doubt is fine if you want to buy shares cheap and sell at a slight premium. Feels to me like you are employing trader tactics - so good luck with it

adreamer sharing vision and logic

Expand

Sorry dreamer but i have been reading positive posters for well over 5 years and where are we, we still havent really progressed with dogs, humans since 2016 and now they throw in covid well lets hope we are not here in four years debating the same lack of progression

PAA Price at posting: 24.0¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 21 more messages in this thread...

First 289 Last

Add PAA (ASX) to my watchlist

(20min delay)
Last 22.0¢		Change -0.010(4.35%)		Mkt cap ! $86.90M

Open	High	Low	Value	Volume
23.0¢	23.5¢	22.0¢	$111.9K	495.0K

Buyers (Bids)

No.	Vol.	Price($)
4	128392	22.0¢

Sellers (Offers)

Price($)	Vol.	No.
23.0¢	48891	4

View Market Depth

No.	Vol.	Price($)
4	128392	0.220
4	62328	0.215
4	136395	0.210
6	63967	0.205
6	79900	0.200

Price($)	Vol.	No.
0.230	48891	4
0.235	159983	3
0.245	61000	4
0.250	364000	5
0.255	75500	2

Last trade - 16.10pm 02/05/2024 (20 minute delay)


Last 22.5¢		Change -0.010 ( 2.17 %)
Open	High	Low	Volume
23.5¢	23.5¢	22.0¢	221305
Last updated 15.23pm 02/05/2024 ?

PAA (ASX) Chart

Clinical Trials, page-289

Featured News

Why Princeton Professor rates BlinkLab's autism & ADHD screening app

Lithium Universe ends the quarter charged up for Quebec Refinery roll-out

Carnarvon revs up for revised Dorado Development

Recharged Prospects: 'Watts' on the horizon for copper & lithium

Provident Aurum's off-market bid sends Sihayo shares soaring

Buyers (Bids)

Sellers (Offers)

Featured News

Clinical Trials, page-289

Featured News

Top Stories

Why Princeton Professor rates BlinkLab's autism & ADHD screening app

Lithium Universe ends the quarter charged up for Quebec Refinery roll-out

Carnarvon revs up for revised Dorado Development

Recharged Prospects: 'Watts' on the horizon for copper & lithium

Provident Aurum's off-market bid sends Sihayo shares soaring

Buyers (Bids)

Sellers (Offers)

Featured News